Momenta Pharmaceuticals,Inc. (NASDAQ:MNTA) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operationsand Financial Condition.
On February21, 2018, Momenta Pharmaceuticals,Inc., a Delaware corporation (“Momenta”), announced its financial results for the year ended December31, 2017. The full text of the press release issued in connection with the announcement is furnished as Exhibit99.1 to this Current Report on Form8-K.
The information in this Current Report on Form8-K (including Exhibit99.1) shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of Momenta under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits.
(d)Exhibits.
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: